These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preliminary evaluation of alpha-adrenergic blocking agents in children with neurogenic bladder due to myelomeningocele. de Voogt HJ, van der Sluis C. Dev Med Child Neurol Suppl; 1976; (37):82-8. PubMed ID: 797616 [Abstract] [Full Text] [Related]
6. Efficacy and safety of mirabegron, a β3-adrenoceptor agonist, for treating neurogenic bladder in pediatric patients with spina bifida: a retrospective pilot study. Park JS, Lee YS, Lee CN, Kim SH, Kim SW, Han SW. World J Urol; 2019 Aug; 37(8):1665-1670. PubMed ID: 30511212 [Abstract] [Full Text] [Related]
11. Management goals for the spina bifida neurogenic bladder: a review from infancy to adulthood. Mourtzinos A, Stoffel JT. Urol Clin North Am; 2010 Nov 13; 37(4):527-35. PubMed ID: 20955904 [Abstract] [Full Text] [Related]
14. Effects of electrotherapy in treatment of neurogenic bladder in children with occult spinal dysraphism. Cirović D, Petronić I, Nikolić D, Brdar R, Pavićević P, Knezević T. Srp Arh Celok Lek; 2009 Nov 13; 137(9-10):502-5. PubMed ID: 19950756 [Abstract] [Full Text] [Related]
15. [Guidelines on the urological management of the adult patient with spinal dysraphism (spina bifida)]. Manunta A, Peyronnet B, Olivari-Philiponnet C, Chartier-Kastler E, Saussine C, Phé V, Robain G, Denys P, Even A, Samson E, Grise P, Karsenty G, Hascoet J, Castel-Lacanal E, Charvier K, Guinet-Lacoste A, Chesnel C, Amarenco G, Haffner F, Haddad M, Le Normand L, Perrouin-Verbe MA, Perrouin-Verbe B, De Seze M, Ruffion A, Gamé X. Prog Urol; 2023 Mar 13; 33(4):178-197. PubMed ID: 36609138 [Abstract] [Full Text] [Related]